PharMerica (PMC) Tops Q4 EPS by 4c, FY Guidance Mixed
Tweet Send to a Friend
PharMerica (NYSE: PMC) reported Q4 EPS of $0.33, $0.04 better than the analyst estimate ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
